Alaunos Therapeutics Inc 's

• TCRT's Stock Performance relative to its Competitors

60 Degrees Pharmaceuticals Inc Share Performance -20.06% 30 Days

60 Degrees Pharmaceuticals Inc Profile 60 Degrees Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of innovative treatments for infectious diseases, particularly malaria. More about 60 Degrees Pharmaceuticals Inc 's Market Share

Boundless Bio Inc Share Performance +1.06% 30 Days

Boundless Bio Inc Profile Audentes Therapeutics Inc is a biotechnology company focused on developing and commercializing innovative gene therapies for serious rare diseases. Their business model revolves around conducting extensive research and development to design and produce these gene therapies. They then collaborate with healthcare providers and regulatory bodies to gain necessary approvals and commercialize their therapies, aiming to provide effective treatments for patients suffering from rare diseases. More about Boundless Bio Inc 's Market Share

Bluebird Bio Inc Share Performance -42.81% This Year

Bluebird Bio Inc Profile Bluebird Bio Inc's business model focuses on developing gene therapies for severe genetic diseases and cancer. They collaborate with academic and industry partners to leverage their gene editing and cell-based technologies for discovering potential treatments and advancing these therapies through clinical trials. More about Bluebird Bio Inc 's Market Share

An2 Therapeutics Inc Share Performance +5.56% Over The Past 5 Days

An2 Therapeutics Inc Profile An2 Therapeutics Inc is a biotechnology company that develops therapeutics for the treatment of rare diseases. Their business model focuses on research and development of innovative drugs that target specific genetic mutations responsible for these rare conditions, aiming to provide effective and personalized treatments. By collaborating with pharmaceutical partners and leveraging their expertise in drug discovery, An2 Therapeutics Inc aims to bring their therapies to market and improve the lives of patients with rare diseases. More about An2 Therapeutics Inc 's Market Share

Unity Biotechnology Inc Share Performance -86.01% One Year

Unity Biotechnology Inc Profile Unity Biotechnology Inc. is a biotechnology company that focuses on developing therapies to treat age-related diseases. Their business model revolves around identifying and targeting specific senescent cells to address age-related conditions like osteoarthritis, kidney disease, and ophthalmic diseases. By leveraging their expertise in cellular senescence, Unity Biotechnology aims to develop innovative treatments that have the potential to extend healthy human lifespan. More about Unity Biotechnology Inc 's Market Share

Sources: Alaunos Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 5, 2026 3:28 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Alaunos Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.